Pharmaceutical Communication in Spain around the COVID-19 Crisis: A Scoping Review

Please use this identifier to cite or link to this item:
Información del item - Informació de l'item - Item information
Title: Pharmaceutical Communication in Spain around the COVID-19 Crisis: A Scoping Review
Authors: Ibáñez-Hernández, Ana Isabel | Papí-Gálvez, Natalia | Carretón-Ballester, Carmen
Research Group/s: Relaciones Públicas, Responsabilidad Social y Comunicación con Públicos Especializados y Las Minorías | Grupo de Estudios sobre Comunicación Estratégica (E-COM)
Center, Department or Service: Universidad de Alicante. Departamento de Comunicación y Psicología Social
Keywords: Pharmaceutical communication | Health literacy | Digital society | Coronavirus | Information overload | Scoping review | PRISMA
Issue Date: 16-Jun-2023
Publisher: MDPI
Citation: Ibáñez-Hernández A, Papí-Gálvez N, Carretón-Ballester C. Pharmaceutical Communication in Spain around the COVID-19 Crisis: A Scoping Review. Systems. 2023; 11(6):309.
Abstract: This paper addresses the scientific production of pharmaceutical communication in Spain around the COVID-19 crisis, in which information overload, amplified by the digital media, evidenced the relevance of communication in the digital society. The research observes the evolution and characteristics of such studies, identifying scientific fields and disciplines related to communication, thematic lines, agents and publics. To this end, it proposes an exploratory review study adjusted to the PRISMA protocol with a search strategy including three databases (Scopus, WOS and Dialnet) and whose filtration produced a final population of 56 publications on Spanish pharmaceutical communication between 2018 and 2022. The results point to a greater production of scientific papers around the year of the pandemic. These papers were published by university institutions in health sciences journals, although differences in authorship by gender were detected. Most of them are empirical papers, with a predominance of mixed content analyses. The field of public relations stands out, but terminological confusion was also detected. This leads to a reflection on its causes and solutions in favour of the transparency and accountability in pharmaceutical communication.
ISSN: 2079-8954
DOI: 10.3390/systems11060309
Language: eng
Type: info:eu-repo/semantics/article
Rights: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (
Peer Review: si
Publisher version:
Appears in Collections:INV - RRPP - Artículos de Revistas
INV - E-COM - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
ThumbnailIbanez-Hernandez_etal_2023_Systems.pdf2,23 MBAdobe PDFOpen Preview

Items in RUA are protected by copyright, with all rights reserved, unless otherwise indicated.